Petros Pharmaceuticals, Inc. Payments of Stock Issuance Costs
Petros Pharmaceuticals, Inc. (PTPI) reported Payments of Stock Issuance Costs of $1.10 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-04-15.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfStockIssuanceCosts · last filed 2026-04-15
- Petros Pharmaceuticals, Inc. payments of stock issuance costs for fiscal 2025 was $1.10M.
- Petros Pharmaceuticals, Inc. payments of stock issuance costs for fiscal 2020 was $1.04M.
| Period end | Payments of Stock Issuance Costs 12 month |
|---|---|
| 2025-12-31 | $1.10M 10-K · filed 2026-04-15 |
| 2020-12-31 | $1.04M 10-K · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B |